Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
McKinsey
Johnson and Johnson
Cerilliant
Colorcon
Fish and Richardson
Daiichi Sankyo
US Army
Fuji

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,880,106

« Back to Dashboard

Summary for Patent: 5,880,106
Title: Oral dosing formulations of dideoxy purine nucleosides
Abstract:Improved oral dosage formulations for acid-labile dideoxy purine nucleoside derivatives such as ddA, ddI, and ddG, have been developed by incorporating selected water-insoluble buffering systems in the formulation. These novel formulations provide reduced mass dosage units in the form of convenient, palatable chewable/dispersible tablets or a dry powder sachet. The reduced mass requirement, necessary to allow tablets of reasonable size, was achieved in part by an unexpected 20 to 25% increase in drug bioavailability resulting from use of the selected buffering systems comprised of an insoluble magnesium antacid agent and either dihydroxyaluminum sodium carbonate or calcium carbonate.
Inventor(s): Ullah; Ismat (Cranbury, NJ), Agharkar; Shreeram Narahari (Princeton, NJ), Wiley; Gary James (Jackson, NJ)
Assignee: Bristol-Myers Squibb Company (Princeton, NJ)
Application Number:08/942,660
Patent Claim Types:
see list of patent claims
Composition; Delivery; Formulation; Compound; Dosage form;

Drugs Protected by US Patent 5,880,106

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 5,880,106

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 163855 ➤ Try a Free Trial
Australia 2039692 ➤ Try a Free Trial
Australia 657337 ➤ Try a Free Trial
Canada 2074215 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Farmers Insurance
Cantor Fitzgerald
Medtronic
US Army
Cerilliant
Express Scripts
Accenture
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.